With the increasing incidence of thoracic tumors, radiation therapy (RT) has become an
important component of comprehensive treatment. RT improves survival in many cancers …

Long-term survivors of Hodgkin lymphoma (HL) experience several late adverse effects of
treatment, with second malignant neoplasms (SMNs) and cardiovascular diseases (CVDs) …

Background Survivors of Hodgkin's lymphoma are at increased risk for treatment-related
subsequent malignant neoplasms. The effect of less toxic treatments, introduced in the late …

Purpose Cardiovascular diseases are increasingly recognized as late effects of Hodgkin
lymphoma (HL) treatment. The purpose of this study was to identify the risk factors for …

Importance Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular
diseases. It is unclear, however, how long the increased risk persists and what the risk …

Background The comparative risks of a second cancer diagnosis are uncertain after primary
cancer treatment with 3‐dimensional conformal radiotherapy (3DCRT), intensity‐modulated …

Improvements in treatment and earlier diagnosis have both contributed to increased survival
for many cancer patients. Unfortunately, many treatments carry a risk of late effects including …

Radiation to the mediastinum is a key component of treatment with curative intent for a range
of cancers including Hodgkin's lymphoma and breast cancer. Exposure to radiation is …

Purpose Hodgkin lymphoma (HL) survivors have an increased risk of cardiovascular
disease (CD), lung cancer, and breast cancer. We investigated the risk for the development …

Purpose Mediastinal radiation therapy (RT) for Hodgkin lymphoma (HL) is associated with
late cardiotoxicity, but there are limited data to indicate which dosimetric parameters are …